Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking.
about
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesOsteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potentialIn utero therapy for congenital disorders using amniotic fluid stem cells.Induced pluripotent stem cells as a cellular model for studying Down Syndrome.Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions.Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases
P2860
Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@en
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@nl
type
label
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@en
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@nl
prefLabel
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@en
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@nl
P2093
P50
P356
P1476
Trisomy 21 mid-trimester amnio ...... ease modeling and cryobanking.
@en
P2093
Agostino Pierro
Anna L David
Drew Ellershaw
Gustavo Mostoslavsky
Jonathan J Waters
Peggy Sung
Sayandip Mukherjee
Steven W Shaw
P304
P356
10.1089/CELL.2013.0091
P50
P577
2014-08-27T00:00:00Z